Association of CD8 T cells with depression and anxiety in patients with liver cirrhosis

International Journal of Psychiatry in Medicine

Volumn 45, Issue 1, 2013, Pages 15-29

  Ko, Fang Yuan ^a   Tsai, Shih Jen ^b   Yang, Albert C ^b   Zhou, Yang ^a   Xu, Lie Ming ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

anxiety; CD8; cirrhosis; depression; T lymphocyte subsets

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; BLOOD ANALYSIS; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHILD PUGH SCORE; CLINICAL ASSESSMENT; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; AGED, 80 AND OVER; ANXIETY; CD8-POSITIVE T-LYMPHOCYTES; COMORBIDITY; DEPRESSION; FEMALE; FLOW CYTOMETRY; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTE SUBSETS;

EID: 84877805546     PISSN: 00912174     EISSN: 15413527     Source Type: Journal    
DOI: 10.2190/PM.45.1.b     Document Type: Article

References (31)

1. Digestive diseases in the United States: Epidemiology and Impact. NIDDK; Bethesda, MD: 1994. NIH Publication No. 94-1447.
2. Haüser W, Holtmann G, Grandt D. Determinants of health related quality of life in patients with chronic liver diseases. Clinical Gastroenterology and Hepatology 2004;2:157-163.
3. Kanwal F, Hays R, Kilbourne AM, Dulai GS, Gralnek IM. Are physician derived disease severity indices associated with health-related quality of life in patients with end-stage liver disease? American Journal of Gastroenterology 2004;99: 1726-1732.
4. Kim SH, Oh EG, Lee WH. Symptom experience, psychological distress, and quality of life in Korean patients with liver cirrhosis: A cross-sectional survey. International Journal of Nursing Studies 2006;43:1047-1056.
5. Bianchi G, Marchesini G, Nicolino F, Graziani R, Sgarbi D, Loguercio C, Abbiati R, Zoli M. Psychological status and depression in patients with liver cirrhosis. Digestive Liver Disease 2005;37:593-600.
6. Bonkovsky HL, Snow KK, Malet PF, Back-Madruga C, Fontana RJ, Sterling RK, Kulig CC, Di Bisceglie AM, Morgan TR, Dienstag JL, Ghany MG, Gretch DR, HALT-C Trial Group. Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis. Journal of Hepatology 2007;46:420-431.
7. Fritz E, Hammer J. Gastrointestinal symptoms in patients with liver cirrhosis are linked to impaired quality of life and psychological distress. European Journal of Gastroenterology and Hepatology 2009;21:460-465.
8. Ziemssen T. Multiple sclerosis beyond the EDSS: Depression and fatigue. Journal of Neurological Science 2009;277(Suppl 1):S37e41.
9. Irwin MR, Miller AH. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behavior and Immunology 2007;21:374-383.
10. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: When the immune system subjugates the brain. National Review of Neuroscience 2008;9:46-56.
11. Laso FJ, Madruga JI, López A, Ciudad J, Alvarez-Mon M, San Miguel J, Orfao A. Distribution of peripheral blood lymphoid subsets in alcoholic liver cirrhosis: Influence of ethanol intake. Alcohol Clinical Experimental Research 1996;20: 1564-1568.
12. Lombardo L, Capaldi A, Poccardi G, Vineis P. Peripheral blood CD3 and CD4 T-lymphocyte reduction correlates with severity of liver cirrhosis. International Journal of Clinical Laboratory Research 1995;25:153-156.
13. Márquez M, Fernández-Gutiérrez C, Montes-de-Oca M, Blanco MJ, Brun F, Rodríguez-Ramos C, Girón-González JA. Chronic antigenic stimuli as a possible explanation for the immunodepression caused by liver cirrhosis. Clinical Experimental Immunology 2009;158:219-229.
14. Sekiguchi T, Nagamine T, Takagi H, Mori M. Reduction of virus burden-induced splenectomy in patients with liver cirrhosis related to hepatitis C virus infection. World Journal of Gastroenterology 2006;12:2089-2094.
15. Chinese Society of Infectious Diseases and Parasitology and Chinese Society of Hepatology of Chinese Medical Association. The programme of prevention and cure for viral hepatitis. Zhonghua Ganzangbing Zazhi 2000;8:324-329.
16. Infante-Rivard C, Esnaola S, Villeneuve JP. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology 1987;7:660-664.
17. Hamilton M. A rating scale for depression. Journal of Neurology and Neurosurgery Psychiatry 1960;23:56-62.
18. Hamilton M. Diagnosis and rating of anxiety. British Journal of Psychiatry 1969; 3:76-79.
19. Zhou FL, Zhang WG, Wei YC, Xu KL, Hui LY, Wang XS, Li MZ. Impact of comorbid anxiety and depression on quality of life and cellular immunity changes in patients with digestive tract cancers. World Journal of Gastroenterology 2005; 11:2313-2318.
20. Serretti A, Cusin C, Lattuada E, Di Bella D, Catalano M, Smeraldi E. Serotonin transporter gene (5-HTTLPR) is not associated with depressive symptomatology in mood disorders. Molecular Psychiatry 1999;4:280-283.
21. Evans DL, Ten Have TR, Douglas SD, Gettes DR, Morrison M, Chiappini MS, Brinker-Spence P, Job C, Mercer DE, Wang YL, Cruess D, Dube B, Dalen EA, Brown T, Bauer R, Petitto JM. Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. American Journal of Psychiatry 2002;159:1752-1759.
22. McCaughan GW, Gorrell MD, Bishop GA, Abbott CA, Shackel NA, McGuinness PH, Levy MT, Sharland AF, Bowen DG, Yu D, Slaitini L, Church WB, Napoli J. Molecular pathogenesis of liver disease: An approach to hepatic inflammation, cirrhosis and liver transplant tolerance. Immunology Review 2000;174:172-191.
23. Dantzer R. Cytokine-induced sickness behavior: Where do we stand? Brain Behavior and Immunology 2001;15:7-24.
24. Huseby ES, Liggitt D, Brabb T, Schnabel B, Ohlén C, Goverman J. A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. Journal of Experimental Medicine 2001;194:669-676.
25. Suidan GL, Dickerson JW, Chen Y, McDole JR, Tripathi P, Pirko I, Seroogy KB, Johnson AJ. CD8 T cell-initiated vascular endothelial growth factor expression promotes central nervous system vascular permeability under neuroinflammatory conditions. Journal of Immunology 2010;184:1031-1040.
26. Suidan GL, Mcdole JR, Chen Y, Pirko I, Johnson AJ. Induction of blood brain barrier tight junction protein alterations by CD8 T cells. PLoS One 2008;3:e3037.
27. Mohr DC, Goodkin DE, Islar J, Hauser SL, Genain CP.Treatment of depression is associated with suppression of nonspecific and antigen-specific T(H)1 responses in multiple sclerosis. Archives of Neurology 2001;58:1081-1086.
28. Lustman PJ, Clouse RE. Treatment of depression in diabetes: Impact on mood and medical outcome. Journal of Psychosomatic Research 2002;53:917-924.
29. Barefoot JC, Burg MM, Carney RM, Cornell CE, Czajkowski SM, Freedland KE, Hosking JD, Khatri P, Pitula CR, Sheps D. Aspects of social support associated with depression at hospitalization and follow-up assessment among cardiac patients. Journal of Cardiopulmonary Rehabilitation 2003;23:404-412.
30. Simon GE, Von Korff M, Lin E. Clinical and functional outcomes of depression treatment in patients with and without chronic medical illness. Psychology and Medicine 2005;35:271-279.
31. Singh N, Gayowski T, Wagener MM, Marino IR. Depression in patients with cirrhosis. Impact on outcome. Digestive Disease Science 1997;42:1421-1427.